 Livemint | IPAB sets aside Indian patent for Roche's Hepatitis C drug Business Standard ... which if not treated, would lead to liver cirrhosis, liver failure and liver cancer, according to the Trust's statement. The patent, granted to Roche in 2006 was the first product patent on a medicine in India under the new TRIPS-mandated product ... Intellectual Property Appellate Board revokes patent on Roche's Pegasys ... |
